FAM99B and hepatocellular carcinoma: [16, 17, 20] confirmed that FAM99A and FAM99B are significantly low expressed in HCC tissues and may be involved in metabolic pathways, and that patients with high expression of FAM99A and FAM99B are predicted to have a better prognosis.